FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.
about
Eosinophilic esophagitis: From pathophysiology to treatmentThe pathophysiology of eosinophilic esophagitisToward uniformity in the diagnosis of eosinophilic esophagitis (EoE): the effect of guidelines on variability of diagnostic criteria for EoE.Impact of gastro-oesophageal reflux on microRNA expression, location and function.Epithelial calcium-sensing receptor activation by eosinophil granule protein analog stimulates collagen matrix contraction.Markers of tyrosine kinase activity in eosinophilic esophagitis: a pilot study of the FIP1L1-PDGFRα fusion gene, pERK 1/2, and pSTAT5.Histomorphological and Immunophenotypic Features of Pill-Induced Esophagitis.HCl-induced and ATP-dependent upregulation of TRPV1 receptor expression and cytokine production by human esophageal epithelial cells.Tissue remodeling in eosinophilic esophagitisCurrent hurdles in the management of eosinophilic oesophagitis: the next steps.Mechanisms of Disease of Eosinophilic Esophagitis.Biology and treatment of eosinophilic esophagitis.An update on the immunopathogenesis of eosinophilic esophagitis.Medical and nutrition management of eosinophilic esophagitis in children.Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease.Eosinophilic gastroenteritis: an update.Adult versus pediatric eosinophilic esophagitis: important differences and similarities for the clinician to understand.Remodeling and fibrosis in chronic eosinophil inflammation.Cellular and molecular immunological mechanisms in eosinophilic esophagitis: an updated overview of their clinical implications.Clinical implications and pathogenesis of esophageal remodeling in eosinophilic esophagitis.Tissue Remodeling in Chronic Eosinophilic Esophageal Inflammation: Parallels in Asthma and Therapeutic Perspectives.The ZnR/GPR39 interacts with the CaSR to enhance signaling in prostate and salivary epithelia.Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression.Antigen presentation and MHC class II expression by human esophageal epithelial cells: role in eosinophilic esophagitis.Increased prevalence of airway reactivity in children with eosinophilic esophagitis.The pathogenesis of eosinophilic esophagitis: beyond the eosinophil.Eotaxin and FGF enhance signaling through an extracellular signal-related kinase (ERK)-dependent pathway in the pathogenesis of Eosinophilic esophagitis.Eosinophilic gastrointestinal diseases--clinically diverse and histopathologically confounding.Diagnosis and treatment of eosinophilic esophagitisCytoskeletal changes induced by allosteric modulators of calcium-sensing receptor in esophageal epithelial cells.Noncanonical NF-κB signaling and the essential kinase NIK modulate crucial features associated with eosinophilic esophagitis pathogenesis.
P2860
Q26776161-B8601F18-6255-49A5-B26E-411C032F0AC6Q27011378-EE75A89C-F3F8-44AA-8953-FBE835F5FE53Q33815129-67567C5C-DCC2-4F20-B0BC-A79E4D1C3D03Q34539123-2703DB67-D421-476B-9649-5D5009719611Q35064735-3A7C1AAD-C9DE-4C9E-A74A-865220F7D161Q35541793-80998930-DD2E-4CE0-ABB7-40C2B1112472Q35654594-34E43548-241E-4058-BA36-208417A1B42FQ36309601-1379B3D3-111E-47FF-87FF-586AB536FC73Q36494364-1FA3B386-D5DC-4E3A-87A9-F752BA698493Q36616776-6022ECA3-2784-4C50-9F20-34A59130B675Q37031313-39B5BE49-67F1-4716-B466-6CA224F9C475Q37549336-4D313AB8-DD59-42CC-88E7-63A4FBECF0D5Q37720740-EB44483B-89CA-4645-9809-173E135F0A45Q37736143-FF5B7488-ACAC-4929-BFC2-6F3D44254C3BQ37828058-5A271D21-84AC-4523-8540-FC0FFF6FD040Q38051704-99F5C04A-129B-4217-95D0-34D7ABDADD65Q38061188-4975904D-2913-467C-8506-17FF5E9CAFC0Q38194002-C7B930DC-FA7F-460B-A274-53282586D736Q38205271-C9DFD242-3533-4776-BDD2-E9704469C783Q38210619-EA104B3E-E0D3-4864-8E2F-17F550A4A910Q38613170-43C302BF-9271-4E8F-8FA2-939E67525B9BQ39058706-D272E005-986B-406D-8E8A-F209CA9D8255Q39390484-58F1A4BD-B920-41DF-B681-B2CE1AE09BC0Q39600165-5CCC7FE8-4688-43C0-8D3A-2B56B0677F29Q41176325-B5D071C0-8E81-4EE5-BE0F-45D0A73355D7Q41476175-B0758F8A-DDF8-475F-B44F-A07B2F2D97E3Q42375196-129C98B2-06CC-47A2-95D2-0DE238697ECAQ42510375-EB9CF4A1-27D9-4026-98CB-203FB42F8664Q42530515-4D647851-4B9A-4CCC-AE5B-1C7F528A8F01Q42645650-7BB6BBD6-9010-4F88-BCC9-DC89D28DA109Q47273589-E9517F96-3BB9-47F0-AD3C-1A3C510DC94E
P2860
FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.
@en
FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.
@nl
type
label
FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.
@en
FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.
@nl
prefLabel
FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.
@en
FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.
@nl
P2093
P2860
P356
P1433
P1476
FGF9-induced proliferative response to eosinophilic inflammation in oesophagitis.
@en
P2093
C J Justinich
D J Hurlbut
D J Mulder
G T Furuta
R J MacLeod
P2860
P304
P356
10.1136/GUT.2008.157628
P407
P577
2008-10-31T00:00:00Z